ArticleInternational journal of immunopathology and pharmacology

Therapeutic drug monitoring and immunogenetic factors associated with the use of adalimumab in Crohn's disease patients.

Livia Moreira Genaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.